In the gene expression study, Zhang et al. (2016) identified calcium-/calmodulin-dependent protein kinase II delta (CAMK2D) as a DEG that may be associated with metastatic prostate cancer. Here, CAMK2D is linked to metastatic prostate carcinoma.